Literature DB >> 17238221

Patient preferences for managing asthma: results from a discrete choice experiment.

Madeleine T King1, Jane Hall, Emily Lancsar, Denzil Fiebig, Ishrat Hossain, Jordan Louviere, Helen K Reddel, Christine R Jenkins.   

Abstract

Effective control of asthma requires regular preventive medication. Poor medication adherence suggests that patient preferences for medications may differ from the concerns of the prescribing clinicians. This study investigated patient preferences for preventive medications across symptom control, daily activities, medication side-effects, convenience and costs, using a discrete choice experiment embedded in a randomized clinical trial involving patients with mild-moderate persistent asthma. The present data were collected after patients had received 6 weeks' treatment with one of two drugs. Three choice options were presented, to continue with the current drug, to change to an alternative, hypothetical drug, or to take no preventive medication. Analysis used random parameter multinomial logit. Most respondents chose to continue with their current drug in most choice situations but this tendency differed depending on which medication they had been allocated. Respondents valued their ability to participate in usual daily activities and sport, preferred minimal symptoms, and were less likely to choose drugs with side-effects. Cost was also significant, but other convenience attributes were not. Demographic characteristics did not improve the model fit. This study illustrates how discrete choice experiments may be embedded in a clinical trial to provide insights into patient preferences. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17238221     DOI: 10.1002/hec.1193

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  24 in total

Review 1.  Discrete choice experiments of pharmacy services: a systematic review.

Authors:  Caroline Vass; Ewan Gray; Katherine Payne
Journal:  Int J Clin Pharm       Date:  2016-06

2.  Which preferred providers are really preferred? Effectiveness of insurers' channeling incentives on pharmacy choice.

Authors:  Lieke H H M Boonen; Frederik T Schut; Bas Donkers; Xander Koolman
Journal:  Int J Health Care Finance Econ       Date:  2009-02-26

3.  Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software.

Authors:  Emily Lancsar; Denzil G Fiebig; Arne Risa Hole
Journal:  Pharmacoeconomics       Date:  2017-07       Impact factor: 4.981

4.  Big Data: Will It Improve Patient-Centered Care?

Authors:  Denzil G Fiebig
Journal:  Patient       Date:  2017-04       Impact factor: 3.883

Review 5.  Reconceptualising the external validity of discrete choice experiments.

Authors:  Emily Lancsar; Joffre Swait
Journal:  Pharmacoeconomics       Date:  2014-10       Impact factor: 4.981

6.  Eliciting preferences to inform patient-centred policies: the case of psoriasis.

Authors:  Aleksandra Torbica; Giovanni Fattore; Fabio Ayala
Journal:  Pharmacoeconomics       Date:  2014-02       Impact factor: 4.981

Review 7.  Understanding Patient Preferences in Medication Nonadherence: A Review of Stated Preference Data.

Authors:  Tracey-Lea Laba; Beverley Essue; Merel Kimman; Stephen Jan
Journal:  Patient       Date:  2015-10       Impact factor: 3.883

8.  Patient preferences for treatment of achilles tendon pain: results from a discrete-choice experiment.

Authors:  Kent R Sweeting; Jennifer A Whitty; Paul A Scuffham; Michael J Yelland
Journal:  Patient       Date:  2011       Impact factor: 3.883

9.  Relationships between personal beliefs and treatment acceptability, and preferences for behavioral treatments.

Authors:  Souraya Sidani; Joyal Miranda; Dana R Epstein; Richard R Bootzin; Jennifer Cousins; Patricia Moritz
Journal:  Behav Res Ther       Date:  2009-06-24

10.  Conducting discrete choice experiments to inform healthcare decision making: a user's guide.

Authors:  Emily Lancsar; Jordan Louviere
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.